nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FMO3—sweat—bipolar disorder	0.0304	0.0711	CbGeAlD
Dasatinib—FMO3—urine—bipolar disorder	0.00865	0.0202	CbGeAlD
Dasatinib—STAT5B—blood plasma—bipolar disorder	0.00838	0.0196	CbGeAlD
Dasatinib—LYN—blood plasma—bipolar disorder	0.00682	0.016	CbGeAlD
Dasatinib—BTK—blood plasma—bipolar disorder	0.00668	0.0156	CbGeAlD
Dasatinib—TEC—thyroid gland—bipolar disorder	0.00507	0.0119	CbGeAlD
Dasatinib—MYT1—nervous system—bipolar disorder	0.00502	0.0117	CbGeAlD
Dasatinib—MAP3K2—blood plasma—bipolar disorder	0.00499	0.0117	CbGeAlD
Dasatinib—MYT1—cerebellum—bipolar disorder	0.00472	0.011	CbGeAlD
Dasatinib—MAPK14—blood plasma—bipolar disorder	0.00469	0.011	CbGeAlD
Dasatinib—JAK2—blood plasma—bipolar disorder	0.00442	0.0103	CbGeAlD
Dasatinib—FYN—blood plasma—bipolar disorder	0.00436	0.0102	CbGeAlD
Dasatinib—EPHB1—thyroid gland—bipolar disorder	0.00398	0.00931	CbGeAlD
Dasatinib—MYT1—brain—bipolar disorder	0.00383	0.00897	CbGeAlD
Dasatinib—SRC—blood plasma—bipolar disorder	0.00378	0.00885	CbGeAlD
Dasatinib—PKMYT1—thyroid gland—bipolar disorder	0.00342	0.00801	CbGeAlD
Dasatinib—CSF1R—blood plasma—bipolar disorder	0.0034	0.00794	CbGeAlD
Dasatinib—EPHB1—nervous system—bipolar disorder	0.00335	0.00783	CbGeAlD
Dasatinib—BMX—thyroid gland—bipolar disorder	0.00334	0.00782	CbGeAlD
Dasatinib—EPHB1—cerebellum—bipolar disorder	0.00315	0.00737	CbGeAlD
Dasatinib—TESK1—adrenal cortex—bipolar disorder	0.00314	0.00735	CbGeAlD
Dasatinib—CYP1A2—urine—bipolar disorder	0.00312	0.0073	CbGeAlD
Dasatinib—STK36—adrenal cortex—bipolar disorder	0.00309	0.00724	CbGeAlD
Dasatinib—KIT—blood plasma—bipolar disorder	0.00308	0.00721	CbGeAlD
Dasatinib—STAT5B—thyroid gland—bipolar disorder	0.00296	0.00693	CbGeAlD
Dasatinib—SIK2—nervous system—bipolar disorder	0.00296	0.00692	CbGeAlD
Dasatinib—PKMYT1—nervous system—bipolar disorder	0.00288	0.00674	CbGeAlD
Dasatinib—CSK—adrenal cortex—bipolar disorder	0.00288	0.00674	CbGeAlD
Dasatinib—HCK—adrenal cortex—bipolar disorder	0.00284	0.00665	CbGeAlD
Dasatinib—EPHB2—nervous system—bipolar disorder	0.00275	0.00643	CbGeAlD
Dasatinib—EPHA3—thyroid gland—bipolar disorder	0.00274	0.00641	CbGeAlD
Dasatinib—PKMYT1—cerebellum—bipolar disorder	0.00271	0.00634	CbGeAlD
Dasatinib—SRMS—nervous system—bipolar disorder	0.00269	0.00629	CbGeAlD
Dasatinib—SIK3—thyroid gland—bipolar disorder	0.00266	0.00623	CbGeAlD
Dasatinib—EPHA8—nervous system—bipolar disorder	0.00263	0.00617	CbGeAlD
Dasatinib—EPHB1—brain—bipolar disorder	0.00256	0.00599	CbGeAlD
Dasatinib—STAT5B—nervous system—bipolar disorder	0.00249	0.00583	CbGeAlD
Dasatinib—EPHA8—cerebellum—bipolar disorder	0.00248	0.0058	CbGeAlD
Dasatinib—ZAK—thyroid gland—bipolar disorder	0.00248	0.00579	CbGeAlD
Dasatinib—BMPR1B—thyroid gland—bipolar disorder	0.00237	0.00555	CbGeAlD
Dasatinib—BTK—thyroid gland—bipolar disorder	0.00236	0.00553	CbGeAlD
Dasatinib—STAT5B—cerebellum—bipolar disorder	0.00234	0.00549	CbGeAlD
Dasatinib—TNK2—thyroid gland—bipolar disorder	0.00233	0.00545	CbGeAlD
Dasatinib—EPHA3—nervous system—bipolar disorder	0.0023	0.00539	CbGeAlD
Dasatinib—FMO3—adrenal cortex—bipolar disorder	0.00229	0.00536	CbGeAlD
Dasatinib—SIK2—brain—bipolar disorder	0.00226	0.00529	CbGeAlD
Dasatinib—CYP3A4—urine—bipolar disorder	0.00226	0.00529	CbGeAlD
Dasatinib—EPHB4—adrenal cortex—bipolar disorder	0.00226	0.00528	CbGeAlD
Dasatinib—SIK3—nervous system—bipolar disorder	0.00224	0.00524	CbGeAlD
Dasatinib—EPHA2—adrenal cortex—bipolar disorder	0.00221	0.00518	CbGeAlD
Dasatinib—PKMYT1—brain—bipolar disorder	0.0022	0.00515	CbGeAlD
Dasatinib—TESK1—thyroid gland—bipolar disorder	0.00219	0.00512	CbGeAlD
Dasatinib—MAP3K3—adrenal cortex—bipolar disorder	0.00216	0.00506	CbGeAlD
Dasatinib—STK36—thyroid gland—bipolar disorder	0.00215	0.00504	CbGeAlD
Dasatinib—SIK3—cerebellum—bipolar disorder	0.00211	0.00493	CbGeAlD
Dasatinib—EPHB2—brain—bipolar disorder	0.0021	0.00492	CbGeAlD
Dasatinib—ZAK—nervous system—bipolar disorder	0.00208	0.00487	CbGeAlD
Dasatinib—LIMK2—thyroid gland—bipolar disorder	0.00208	0.00487	CbGeAlD
Dasatinib—SRMS—brain—bipolar disorder	0.00206	0.00481	CbGeAlD
Dasatinib—EPHA5—nervous system—bipolar disorder	0.00204	0.00477	CbGeAlD
Dasatinib—LYN—nervous system—bipolar disorder	0.00203	0.00474	CbGeAlD
Dasatinib—STK35—thyroid gland—bipolar disorder	0.00202	0.00472	CbGeAlD
Dasatinib—EPHA8—brain—bipolar disorder	0.00201	0.00471	CbGeAlD
Dasatinib—CSK—thyroid gland—bipolar disorder	0.00201	0.00469	CbGeAlD
Dasatinib—BMPR1B—nervous system—bipolar disorder	0.002	0.00467	CbGeAlD
Dasatinib—MAP3K19—nervous system—bipolar disorder	0.002	0.00467	CbGeAlD
Dasatinib—YES1—adrenal cortex—bipolar disorder	0.002	0.00467	CbGeAlD
Dasatinib—HCK—thyroid gland—bipolar disorder	0.00198	0.00463	CbGeAlD
Dasatinib—ABL2—thyroid gland—bipolar disorder	0.00197	0.0046	CbGeAlD
Dasatinib—ZAK—cerebellum—bipolar disorder	0.00196	0.00459	CbGeAlD
Dasatinib—TNK2—nervous system—bipolar disorder	0.00196	0.00458	CbGeAlD
Dasatinib—EPHA5—cerebellum—bipolar disorder	0.00192	0.00449	CbGeAlD
Dasatinib—STAT5B—brain—bipolar disorder	0.0019	0.00446	CbGeAlD
Dasatinib—BMPR1B—cerebellum—bipolar disorder	0.00188	0.0044	CbGeAlD
Dasatinib—RIPK2—thyroid gland—bipolar disorder	0.00186	0.00436	CbGeAlD
Dasatinib—TNK2—cerebellum—bipolar disorder	0.00184	0.00431	CbGeAlD
Dasatinib—TESK1—nervous system—bipolar disorder	0.00184	0.00431	CbGeAlD
Dasatinib—SIK1—thyroid gland—bipolar disorder	0.00182	0.00425	CbGeAlD
Dasatinib—EPHB3—nervous system—bipolar disorder	0.00181	0.00424	CbGeAlD
Dasatinib—STK36—nervous system—bipolar disorder	0.00181	0.00424	CbGeAlD
Dasatinib—EPHA4—thyroid gland—bipolar disorder	0.0018	0.00421	CbGeAlD
Dasatinib—ERBB3—thyroid gland—bipolar disorder	0.00178	0.00417	CbGeAlD
Dasatinib—MAP2K5—adrenal cortex—bipolar disorder	0.00177	0.00413	CbGeAlD
Dasatinib—MAP3K2—thyroid gland—bipolar disorder	0.00176	0.00413	CbGeAlD
Dasatinib—EPHA3—brain—bipolar disorder	0.00176	0.00412	CbGeAlD
Dasatinib—LIMK2—nervous system—bipolar disorder	0.00175	0.0041	CbGeAlD
Dasatinib—TESK1—cerebellum—bipolar disorder	0.00173	0.00405	CbGeAlD
Dasatinib—CSF1R—adrenal cortex—bipolar disorder	0.00172	0.00403	CbGeAlD
Dasatinib—SIK3—brain—bipolar disorder	0.00171	0.00401	CbGeAlD
Dasatinib—STK36—cerebellum—bipolar disorder	0.0017	0.00399	CbGeAlD
Dasatinib—EPHB3—cerebellum—bipolar disorder	0.0017	0.00399	CbGeAlD
Dasatinib—STK35—nervous system—bipolar disorder	0.0017	0.00397	CbGeAlD
Dasatinib—CSK—nervous system—bipolar disorder	0.00169	0.00395	CbGeAlD
Dasatinib—HCK—nervous system—bipolar disorder	0.00166	0.0039	CbGeAlD
Dasatinib—MAPK14—thyroid gland—bipolar disorder	0.00166	0.00388	CbGeAlD
Dasatinib—FGR—thyroid gland—bipolar disorder	0.00165	0.00387	CbGeAlD
Dasatinib—LCK—thyroid gland—bipolar disorder	0.00165	0.00387	CbGeAlD
Dasatinib—LIMK2—cerebellum—bipolar disorder	0.00165	0.00386	CbGeAlD
Dasatinib—CYP1A2—blood plasma—bipolar disorder	0.00163	0.00381	CbGeAlD
Dasatinib—STK35—cerebellum—bipolar disorder	0.0016	0.00374	CbGeAlD
Dasatinib—FMO3—thyroid gland—bipolar disorder	0.0016	0.00373	CbGeAlD
Dasatinib—ZAK—brain—bipolar disorder	0.00159	0.00373	CbGeAlD
Dasatinib—CSK—cerebellum—bipolar disorder	0.00159	0.00371	CbGeAlD
Dasatinib—EPHB4—thyroid gland—bipolar disorder	0.00157	0.00368	CbGeAlD
Dasatinib—CYP3A5—blood plasma—bipolar disorder	0.00157	0.00368	CbGeAlD
Dasatinib—JAK2—thyroid gland—bipolar disorder	0.00156	0.00365	CbGeAlD
Dasatinib—EPHA5—brain—bipolar disorder	0.00156	0.00365	CbGeAlD
Dasatinib—ABL2—cerebellum—bipolar disorder	0.00156	0.00364	CbGeAlD
Dasatinib—LYN—brain—bipolar disorder	0.00155	0.00363	CbGeAlD
Dasatinib—EPHA2—thyroid gland—bipolar disorder	0.00154	0.00361	CbGeAlD
Dasatinib—FYN—thyroid gland—bipolar disorder	0.00154	0.0036	CbGeAlD
Dasatinib—SIK1—nervous system—bipolar disorder	0.00153	0.00358	CbGeAlD
Dasatinib—PDGFRB—adrenal cortex—bipolar disorder	0.00153	0.00358	CbGeAlD
Dasatinib—BMPR1B—brain—bipolar disorder	0.00153	0.00357	CbGeAlD
Dasatinib—MAP3K19—brain—bipolar disorder	0.00153	0.00357	CbGeAlD
Dasatinib—BTK—brain—bipolar disorder	0.00152	0.00355	CbGeAlD
Dasatinib—EPHA4—nervous system—bipolar disorder	0.00151	0.00354	CbGeAlD
Dasatinib—MAP4K5—thyroid gland—bipolar disorder	0.0015	0.00352	CbGeAlD
Dasatinib—MAP3K3—thyroid gland—bipolar disorder	0.0015	0.00352	CbGeAlD
Dasatinib—ERBB3—nervous system—bipolar disorder	0.0015	0.00351	CbGeAlD
Dasatinib—TNK2—brain—bipolar disorder	0.0015	0.0035	CbGeAlD
Dasatinib—MAP3K2—nervous system—bipolar disorder	0.00148	0.00347	CbGeAlD
Dasatinib—RIPK2—cerebellum—bipolar disorder	0.00147	0.00345	CbGeAlD
Dasatinib—SIK1—cerebellum—bipolar disorder	0.00144	0.00337	CbGeAlD
Dasatinib—EPHB6—thyroid gland—bipolar disorder	0.00144	0.00337	CbGeAlD
Dasatinib—EPHA4—cerebellum—bipolar disorder	0.00142	0.00333	CbGeAlD
Dasatinib—ERBB3—cerebellum—bipolar disorder	0.00141	0.0033	CbGeAlD
Dasatinib—TESK1—brain—bipolar disorder	0.00141	0.00329	CbGeAlD
Dasatinib—MAP3K2—cerebellum—bipolar disorder	0.0014	0.00327	CbGeAlD
Dasatinib—MAPK14—nervous system—bipolar disorder	0.0014	0.00326	CbGeAlD
Dasatinib—YES1—thyroid gland—bipolar disorder	0.00139	0.00325	CbGeAlD
Dasatinib—FGR—nervous system—bipolar disorder	0.00139	0.00325	CbGeAlD
Dasatinib—EPHB3—brain—bipolar disorder	0.00138	0.00324	CbGeAlD
Dasatinib—STK36—brain—bipolar disorder	0.00138	0.00324	CbGeAlD
Dasatinib—PDGFRA—thyroid gland—bipolar disorder	0.00136	0.00319	CbGeAlD
Dasatinib—ABL1—adrenal cortex—bipolar disorder	0.00136	0.00319	CbGeAlD
Dasatinib—FMO3—nervous system—bipolar disorder	0.00134	0.00314	CbGeAlD
Dasatinib—LIMK2—brain—bipolar disorder	0.00134	0.00313	CbGeAlD
Dasatinib—SRC—thyroid gland—bipolar disorder	0.00134	0.00313	CbGeAlD
Dasatinib—JAK2—nervous system—bipolar disorder	0.00131	0.00307	CbGeAlD
Dasatinib—MAPK14—cerebellum—bipolar disorder	0.00131	0.00307	CbGeAlD
Dasatinib—STK35—brain—bipolar disorder	0.0013	0.00304	CbGeAlD
Dasatinib—EPHA2—nervous system—bipolar disorder	0.0013	0.00304	CbGeAlD
Dasatinib—FYN—nervous system—bipolar disorder	0.0013	0.00303	CbGeAlD
Dasatinib—CSK—brain—bipolar disorder	0.00129	0.00302	CbGeAlD
Dasatinib—HCK—brain—bipolar disorder	0.00127	0.00298	CbGeAlD
Dasatinib—MAP3K3—nervous system—bipolar disorder	0.00127	0.00296	CbGeAlD
Dasatinib—MAP4K5—nervous system—bipolar disorder	0.00127	0.00296	CbGeAlD
Dasatinib—ABL2—brain—bipolar disorder	0.00126	0.00296	CbGeAlD
Dasatinib—EPHB4—cerebellum—bipolar disorder	0.00124	0.00291	CbGeAlD
Dasatinib—JAK2—cerebellum—bipolar disorder	0.00124	0.00289	CbGeAlD
Dasatinib—MAP2K5—thyroid gland—bipolar disorder	0.00123	0.00288	CbGeAlD
Dasatinib—FYN—cerebellum—bipolar disorder	0.00122	0.00285	CbGeAlD
Dasatinib—EPHB6—nervous system—bipolar disorder	0.00121	0.00283	CbGeAlD
Dasatinib—CSF1R—thyroid gland—bipolar disorder	0.0012	0.00281	CbGeAlD
Dasatinib—RIPK2—brain—bipolar disorder	0.0012	0.0028	CbGeAlD
Dasatinib—MAP4K5—cerebellum—bipolar disorder	0.00119	0.00279	CbGeAlD
Dasatinib—MAP3K3—cerebellum—bipolar disorder	0.00119	0.00279	CbGeAlD
Dasatinib—CYP3A4—blood plasma—bipolar disorder	0.00118	0.00276	CbGeAlD
Dasatinib—YES1—nervous system—bipolar disorder	0.00117	0.00274	CbGeAlD
Dasatinib—SIK1—brain—bipolar disorder	0.00117	0.00273	CbGeAlD
Dasatinib—EPHA4—brain—bipolar disorder	0.00116	0.00271	CbGeAlD
Dasatinib—PDGFRA—nervous system—bipolar disorder	0.00115	0.00268	CbGeAlD
Dasatinib—ERBB3—brain—bipolar disorder	0.00115	0.00268	CbGeAlD
Dasatinib—EPHB6—cerebellum—bipolar disorder	0.00114	0.00266	CbGeAlD
Dasatinib—MAP3K2—brain—bipolar disorder	0.00113	0.00265	CbGeAlD
Dasatinib—SRC—nervous system—bipolar disorder	0.00112	0.00263	CbGeAlD
Dasatinib—YES1—cerebellum—bipolar disorder	0.0011	0.00257	CbGeAlD
Dasatinib—KIT—thyroid gland—bipolar disorder	0.00109	0.00255	CbGeAlD
Dasatinib—PDGFRA—cerebellum—bipolar disorder	0.00108	0.00253	CbGeAlD
Dasatinib—MAPK14—brain—bipolar disorder	0.00107	0.0025	CbGeAlD
Dasatinib—PDGFRB—thyroid gland—bipolar disorder	0.00106	0.00249	CbGeAlD
Dasatinib—FGR—brain—bipolar disorder	0.00106	0.00249	CbGeAlD
Dasatinib—SRC—cerebellum—bipolar disorder	0.00106	0.00248	CbGeAlD
Dasatinib—MAP2K5—nervous system—bipolar disorder	0.00103	0.00242	CbGeAlD
Dasatinib—FMO3—brain—bipolar disorder	0.00103	0.0024	CbGeAlD
Dasatinib—EPHB4—brain—bipolar disorder	0.00101	0.00237	CbGeAlD
Dasatinib—CSF1R—nervous system—bipolar disorder	0.00101	0.00236	CbGeAlD
Dasatinib—JAK2—brain—bipolar disorder	0.001	0.00235	CbGeAlD
Dasatinib—EPHA2—brain—bipolar disorder	0.000992	0.00232	CbGeAlD
Dasatinib—FYN—brain—bipolar disorder	0.00099	0.00232	CbGeAlD
Dasatinib—MAP2K5—cerebellum—bipolar disorder	0.000974	0.00228	CbGeAlD
Dasatinib—MAP3K3—brain—bipolar disorder	0.000968	0.00226	CbGeAlD
Dasatinib—MAP4K5—brain—bipolar disorder	0.000968	0.00226	CbGeAlD
Dasatinib—CSF1R—cerebellum—bipolar disorder	0.00095	0.00222	CbGeAlD
Dasatinib—ABL1—thyroid gland—bipolar disorder	0.000949	0.00222	CbGeAlD
Dasatinib—EPHB6—brain—bipolar disorder	0.000925	0.00216	CbGeAlD
Dasatinib—KIT—nervous system—bipolar disorder	0.000917	0.00215	CbGeAlD
Dasatinib—PDGFRB—nervous system—bipolar disorder	0.000895	0.0021	CbGeAlD
Dasatinib—YES1—brain—bipolar disorder	0.000894	0.00209	CbGeAlD
Dasatinib—PDGFRA—brain—bipolar disorder	0.000877	0.00205	CbGeAlD
Dasatinib—KIT—cerebellum—bipolar disorder	0.000863	0.00202	CbGeAlD
Dasatinib—SRC—brain—bipolar disorder	0.00086	0.00201	CbGeAlD
Dasatinib—ABCG2—adrenal cortex—bipolar disorder	0.000859	0.00201	CbGeAlD
Dasatinib—PDGFRB—cerebellum—bipolar disorder	0.000843	0.00197	CbGeAlD
Dasatinib—ABCB1—blood plasma—bipolar disorder	0.000835	0.00195	CbGeAlD
Dasatinib—CYP1B1—thyroid gland—bipolar disorder	0.000804	0.00188	CbGeAlD
Dasatinib—ABL1—nervous system—bipolar disorder	0.000798	0.00187	CbGeAlD
Dasatinib—MAP2K5—brain—bipolar disorder	0.000791	0.00185	CbGeAlD
Dasatinib—CSF1R—brain—bipolar disorder	0.000772	0.00181	CbGeAlD
Dasatinib—ABL1—cerebellum—bipolar disorder	0.000751	0.00176	CbGeAlD
Dasatinib—KIT—brain—bipolar disorder	0.000701	0.00164	CbGeAlD
Dasatinib—PDGFRB—brain—bipolar disorder	0.000684	0.0016	CbGeAlD
Dasatinib—CYP1B1—nervous system—bipolar disorder	0.000676	0.00158	CbGeAlD
Dasatinib—CYP1B1—cerebellum—bipolar disorder	0.000636	0.00149	CbGeAlD
Dasatinib—ABL1—brain—bipolar disorder	0.00061	0.00143	CbGeAlD
Dasatinib—ABCG2—thyroid gland—bipolar disorder	0.000598	0.0014	CbGeAlD
Dasatinib—CYP1A2—thyroid gland—bipolar disorder	0.000576	0.00135	CbGeAlD
Dasatinib—CYP1A1—thyroid gland—bipolar disorder	0.000568	0.00133	CbGeAlD
Dasatinib—CYP1B1—brain—bipolar disorder	0.000517	0.00121	CbGeAlD
Dasatinib—CYP1A1—nervous system—bipolar disorder	0.000478	0.00112	CbGeAlD
Dasatinib—ABCG2—cerebellum—bipolar disorder	0.000474	0.00111	CbGeAlD
Dasatinib—ABCB1—adrenal cortex—bipolar disorder	0.000424	0.000991	CbGeAlD
Dasatinib—ABCG2—brain—bipolar disorder	0.000385	0.0009	CbGeAlD
Dasatinib—CYP1A1—brain—bipolar disorder	0.000365	0.000855	CbGeAlD
Dasatinib—CYP3A4—nervous system—bipolar disorder	0.000351	0.00082	CbGeAlD
Dasatinib—ABCB1—thyroid gland—bipolar disorder	0.000295	0.00069	CbGeAlD
Dasatinib—ABCB1—nervous system—bipolar disorder	0.000248	0.000581	CbGeAlD
Dasatinib—ABCB1—cerebellum—bipolar disorder	0.000234	0.000546	CbGeAlD
Dasatinib—ABCB1—brain—bipolar disorder	0.00019	0.000444	CbGeAlD
Dasatinib—PDGFRB—Disease—MTHFR—bipolar disorder	2.13e-05	3.72e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NDUFV2—bipolar disorder	2.13e-05	3.71e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—DRD4—bipolar disorder	2.12e-05	3.71e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—ADCY2—bipolar disorder	2.11e-05	3.68e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TCF7L2—bipolar disorder	2.1e-05	3.67e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—DRD4—bipolar disorder	2.1e-05	3.66e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—DRD2—bipolar disorder	2.09e-05	3.64e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—S100B—bipolar disorder	2.08e-05	3.64e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CLOCK—bipolar disorder	2.08e-05	3.63e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—ADCY2—bipolar disorder	2.08e-05	3.62e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TCF7L2—bipolar disorder	2.07e-05	3.61e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—GSK3B—bipolar disorder	2.06e-05	3.6e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—S100B—bipolar disorder	2.06e-05	3.6e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AKR1C4—bipolar disorder	2.06e-05	3.6e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—NRG1—bipolar disorder	2.05e-05	3.59e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—DRD2—bipolar disorder	2.05e-05	3.59e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—MTHFR—bipolar disorder	2.05e-05	3.58e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL1B—bipolar disorder	2.05e-05	3.57e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—GSK3B—bipolar disorder	2.04e-05	3.56e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—POMC—bipolar disorder	2.04e-05	3.55e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—TSHB—bipolar disorder	2.03e-05	3.54e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—TPH2—bipolar disorder	2.03e-05	3.54e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CACNB2—bipolar disorder	2.03e-05	3.54e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—POMC—bipolar disorder	2.02e-05	3.53e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR1A—bipolar disorder	2.02e-05	3.53e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—GSK3B—bipolar disorder	2.01e-05	3.51e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—INS—bipolar disorder	2.01e-05	3.51e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ADCY2—bipolar disorder	2e-05	3.5e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—ADCY2—bipolar disorder	2e-05	3.49e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—DPYD—bipolar disorder	1.99e-05	3.48e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TCF7L2—bipolar disorder	1.99e-05	3.48e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TAC1—bipolar disorder	1.99e-05	3.48e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—INS—bipolar disorder	1.98e-05	3.47e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—DRD2—bipolar disorder	1.98e-05	3.45e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—ADCY2—bipolar disorder	1.97e-05	3.44e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TCF7L2—bipolar disorder	1.97e-05	3.43e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CLOCK—bipolar disorder	1.97e-05	3.43e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HTR2A—bipolar disorder	1.96e-05	3.42e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR2C—bipolar disorder	1.95e-05	3.41e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—DRD2—bipolar disorder	1.95e-05	3.41e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD1—bipolar disorder	1.95e-05	3.41e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—MTHFR—bipolar disorder	1.95e-05	3.4e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NRG1—bipolar disorder	1.94e-05	3.39e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—IMPA1—bipolar disorder	1.93e-05	3.37e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NTRK1—bipolar disorder	1.93e-05	3.37e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—TPH2—bipolar disorder	1.92e-05	3.34e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—TSHB—bipolar disorder	1.92e-05	3.34e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CACNB2—bipolar disorder	1.92e-05	3.34e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—GSK3B—bipolar disorder	1.9e-05	3.33e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NTRK2—bipolar disorder	1.9e-05	3.32e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—NRG1—bipolar disorder	1.9e-05	3.31e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD3—bipolar disorder	1.89e-05	3.3e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NTRK1—bipolar disorder	1.89e-05	3.3e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—COMT—bipolar disorder	1.88e-05	3.29e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—DPYD—bipolar disorder	1.88e-05	3.29e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—GSK3A—bipolar disorder	1.88e-05	3.29e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—INS—bipolar disorder	1.88e-05	3.28e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—S100B—bipolar disorder	1.88e-05	3.27e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—MAOA—bipolar disorder	1.87e-05	3.27e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	1.86e-05	3.26e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NTRK1—bipolar disorder	1.86e-05	3.25e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—GSK3B—bipolar disorder	1.86e-05	3.25e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CACNA1C—bipolar disorder	1.85e-05	3.24e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NR1D1—bipolar disorder	1.85e-05	3.23e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	1.85e-05	3.23e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—POMC—bipolar disorder	1.85e-05	3.23e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—INS—bipolar disorder	1.84e-05	3.21e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NRG1—bipolar disorder	1.84e-05	3.21e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—S100B—bipolar disorder	1.84e-05	3.21e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD4—bipolar disorder	1.84e-05	3.21e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—GSK3B—bipolar disorder	1.82e-05	3.18e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—NRG1—bipolar disorder	1.82e-05	3.18e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—GSK3B—bipolar disorder	1.81e-05	3.16e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—S100B—bipolar disorder	1.81e-05	3.16e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	1.81e-05	3.16e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—GSK3B—bipolar disorder	1.8e-05	3.14e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL1B—bipolar disorder	1.8e-05	3.14e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—GSK3B—bipolar disorder	1.79e-05	3.13e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NTRK1—bipolar disorder	1.79e-05	3.13e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR1A—bipolar disorder	1.79e-05	3.12e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—POMC—bipolar disorder	1.78e-05	3.11e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—INS—bipolar disorder	1.77e-05	3.1e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NCAN—bipolar disorder	1.77e-05	3.09e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NTRK1—bipolar disorder	1.77e-05	3.09e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TAC1—bipolar disorder	1.76e-05	3.08e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CACNA1C—bipolar disorder	1.75e-05	3.06e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HTR2A—bipolar disorder	1.75e-05	3.06e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—S100B—bipolar disorder	1.74e-05	3.04e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC5A3—bipolar disorder	1.73e-05	3.03e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2C—bipolar disorder	1.73e-05	3.02e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD1—bipolar disorder	1.73e-05	3.02e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—ADCY2—bipolar disorder	1.73e-05	3.02e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—GSK3B—bipolar disorder	1.72e-05	3.01e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TCF7L2—bipolar disorder	1.72e-05	3.01e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—S100B—bipolar disorder	1.72e-05	3e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—GSK3B—bipolar disorder	1.72e-05	3e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—COMT—bipolar disorder	1.71e-05	2.99e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD2—bipolar disorder	1.71e-05	2.99e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—MTHFR—bipolar disorder	1.71e-05	2.98e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	1.71e-05	2.98e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—GSK3B—bipolar disorder	1.7e-05	2.97e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—MAOA—bipolar disorder	1.7e-05	2.97e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—INS—bipolar disorder	1.69e-05	2.96e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.68e-05	2.94e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NTRK2—bipolar disorder	1.68e-05	2.94e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NRG1—bipolar disorder	1.68e-05	2.93e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD3—bipolar disorder	1.67e-05	2.92e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—GSK3A—bipolar disorder	1.67e-05	2.91e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HTR2A—bipolar disorder	1.66e-05	2.89e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NRG1—bipolar disorder	1.66e-05	2.89e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—GSK3B—bipolar disorder	1.65e-05	2.89e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.64e-05	2.87e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—INS—bipolar disorder	1.63e-05	2.85e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD4—bipolar disorder	1.62e-05	2.84e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—SNAP25—bipolar disorder	1.62e-05	2.83e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NRG1—bipolar disorder	1.62e-05	2.83e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL1B—bipolar disorder	1.6e-05	2.8e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NRG1—bipolar disorder	1.6e-05	2.79e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.59e-05	2.78e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—GSK3B—bipolar disorder	1.58e-05	2.75e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—GSK3B—bipolar disorder	1.57e-05	2.75e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CLOCK—bipolar disorder	1.57e-05	2.74e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—POMC—bipolar disorder	1.56e-05	2.73e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—INS—bipolar disorder	1.56e-05	2.72e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—INS—bipolar disorder	1.55e-05	2.71e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NTRK1—bipolar disorder	1.55e-05	2.7e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NRG1—bipolar disorder	1.54e-05	2.68e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—SNAP25—bipolar disorder	1.53e-05	2.67e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—TSHB—bipolar disorder	1.53e-05	2.67e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—TPH2—bipolar disorder	1.53e-05	2.67e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CACNB2—bipolar disorder	1.53e-05	2.67e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ADCY2—bipolar disorder	1.53e-05	2.67e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TCF7L2—bipolar disorder	1.52e-05	2.66e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—MTHFR—bipolar disorder	1.52e-05	2.66e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL1B—bipolar disorder	1.52e-05	2.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NRG1—bipolar disorder	1.52e-05	2.65e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD2—bipolar disorder	1.51e-05	2.64e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—MTHFR—bipolar disorder	1.51e-05	2.64e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—S100B—bipolar disorder	1.5e-05	2.63e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—DPYD—bipolar disorder	1.5e-05	2.63e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HTR2A—bipolar disorder	1.49e-05	2.61e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—GSK3B—bipolar disorder	1.49e-05	2.6e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HTR2A—bipolar disorder	1.46e-05	2.55e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HTR2A—bipolar disorder	1.44e-05	2.51e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ADCY2—bipolar disorder	1.43e-05	2.5e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.43e-05	2.49e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—GSK3B—bipolar disorder	1.41e-05	2.46e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CACNA1C—bipolar disorder	1.4e-05	2.44e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—POMC—bipolar disorder	1.4e-05	2.44e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—INS—bipolar disorder	1.39e-05	2.43e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—MTHFR—bipolar disorder	1.39e-05	2.42e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HTR2A—bipolar disorder	1.39e-05	2.42e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—GSK3B—bipolar disorder	1.38e-05	2.4e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NTRK1—bipolar disorder	1.37e-05	2.39e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL1B—bipolar disorder	1.37e-05	2.39e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HTR2A—bipolar disorder	1.37e-05	2.39e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NCAN—bipolar disorder	1.37e-05	2.38e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	1.36e-05	2.38e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—INS—bipolar disorder	1.36e-05	2.37e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ADCY2—bipolar disorder	1.35e-05	2.37e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL1B—bipolar disorder	1.34e-05	2.34e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.34e-05	2.34e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—GSK3B—bipolar disorder	1.33e-05	2.33e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL1B—bipolar disorder	1.33e-05	2.33e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—S100B—bipolar disorder	1.33e-05	2.33e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NRG1—bipolar disorder	1.33e-05	2.32e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—POMC—bipolar disorder	1.32e-05	2.31e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—GSK3B—bipolar disorder	1.32e-05	2.31e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL1B—bipolar disorder	1.32e-05	2.3e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—INS—bipolar disorder	1.32e-05	2.3e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1B—bipolar disorder	1.27e-05	2.22e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1B—bipolar disorder	1.25e-05	2.19e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CLOCK—bipolar disorder	1.25e-05	2.19e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—COMT—bipolar disorder	1.23e-05	2.14e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SNAP25—bipolar disorder	1.22e-05	2.14e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TPH2—bipolar disorder	1.22e-05	2.13e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TSHB—bipolar disorder	1.22e-05	2.13e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CACNB2—bipolar disorder	1.22e-05	2.13e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MAOA—bipolar disorder	1.22e-05	2.13e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—GSK3B—bipolar disorder	1.22e-05	2.13e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—POMC—bipolar disorder	1.22e-05	2.13e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—INS—bipolar disorder	1.21e-05	2.12e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—INS—bipolar disorder	1.2e-05	2.1e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—GSK3B—bipolar disorder	1.2e-05	2.1e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—DPYD—bipolar disorder	1.2e-05	2.1e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR2A—bipolar disorder	1.2e-05	2.09e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—POMC—bipolar disorder	1.19e-05	2.08e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—INS—bipolar disorder	1.19e-05	2.07e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—GSK3B—bipolar disorder	1.18e-05	2.05e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NRG1—bipolar disorder	1.18e-05	2.05e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—POMC—bipolar disorder	1.17e-05	2.04e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—INS—bipolar disorder	1.16e-05	2.03e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—COMT—bipolar disorder	1.16e-05	2.03e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—GSK3B—bipolar disorder	1.16e-05	2.02e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MAOA—bipolar disorder	1.15e-05	2.01e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—POMC—bipolar disorder	1.15e-05	2.01e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—INS—bipolar disorder	1.14e-05	1.99e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CACNA1C—bipolar disorder	1.12e-05	1.95e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—GSK3B—bipolar disorder	1.12e-05	1.95e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—bipolar disorder	1.11e-05	1.94e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—bipolar disorder	1.11e-05	1.93e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—INS—bipolar disorder	1.1e-05	1.92e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—GSK3B—bipolar disorder	1.1e-05	1.92e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—INS—bipolar disorder	1.1e-05	1.92e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—bipolar disorder	1.1e-05	1.92e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—bipolar disorder	1.09e-05	1.91e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	1.09e-05	1.9e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—INS—bipolar disorder	1.09e-05	1.9e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ADCY2—bipolar disorder	1.08e-05	1.89e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.07e-05	1.88e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—bipolar disorder	1.06e-05	1.85e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MTHFR—bipolar disorder	9.93e-06	1.73e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SNAP25—bipolar disorder	9.76e-06	1.7e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—bipolar disorder	9.72e-06	1.7e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CLOCK—bipolar disorder	9.67e-06	1.69e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—GSK3B—bipolar disorder	9.64e-06	1.68e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—bipolar disorder	9.56e-06	1.67e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—INS—bipolar disorder	9.51e-06	1.66e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TSHB—bipolar disorder	9.42e-06	1.65e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TPH2—bipolar disorder	9.42e-06	1.65e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CACNB2—bipolar disorder	9.42e-06	1.65e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MTHFR—bipolar disorder	9.38e-06	1.64e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DPYD—bipolar disorder	9.27e-06	1.62e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—COMT—bipolar disorder	9.27e-06	1.62e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MAOA—bipolar disorder	9.2e-06	1.61e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADCY2—bipolar disorder	8.64e-06	1.51e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	8.62e-06	1.51e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—GSK3B—bipolar disorder	8.54e-06	1.49e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—bipolar disorder	8.47e-06	1.48e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—INS—bipolar disorder	8.42e-06	1.47e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	8.4e-06	1.47e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—bipolar disorder	7.94e-06	1.39e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—INS—bipolar disorder	7.9e-06	1.38e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SNAP25—bipolar disorder	7.53e-06	1.32e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—bipolar disorder	7.5e-06	1.31e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—bipolar disorder	7.49e-06	1.31e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—INS—bipolar disorder	7.46e-06	1.3e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—COMT—bipolar disorder	7.4e-06	1.29e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MAOA—bipolar disorder	7.35e-06	1.28e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADCY2—bipolar disorder	6.67e-06	1.16e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—bipolar disorder	5.99e-06	1.05e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—bipolar disorder	5.98e-06	1.04e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—INS—bipolar disorder	5.96e-06	1.04e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—COMT—bipolar disorder	5.71e-06	9.97e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOA—bipolar disorder	5.67e-06	9.9e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—bipolar disorder	4.78e-06	8.35e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—INS—bipolar disorder	4.76e-06	8.31e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—bipolar disorder	4.62e-06	8.06e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—bipolar disorder	3.69e-06	6.45e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—INS—bipolar disorder	3.67e-06	6.41e-06	CbGpPWpGaD
